Loading stock data...

Jubilant Ingrevia Limited

NSE: JUBLINGREA BSE: JUBLINGREA

NSE
600.75 20.20 (3.48%)

Prev Close

580.55

Open Price

570.45

Volume

358,488

Today Low / High

567.8 / 612.05

52 WK Low / High

422 / 885

Range

571 - 631

BSE
602.45 21.95 (3.78%)

Prev Close

580.5

Open Price

578.95

Volume

6,552

Today Low / High

569.7 / 613.15

52 WK Low / High

422 / 884.95

Range

572 - 633

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 600.75 (target range: 571 - 631), reflecting a change of 20.2 (3.47946%). On the BSE, it is listed at 602.45 (target range: 572 - 633), showing a change of 21.95 (3.78122%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

04 Mar 570.45 5.43%
03 Mar 617.50 -5.98%
28 Feb 638.65 -3.52%
27 Feb 684.00 -5.20%
25 Feb 661.00 3.60%
24 Feb 672.30 -0.45%
21 Feb 681.95 -0.32%
20 Feb 669.35 1.85%
19 Feb 643.05 5.61%
18 Feb 650.00 -0.80%
17 Feb 615.10 4.89%
14 Feb 662.00 -4.78%
13 Feb 675.00 -2.27%
12 Feb 693.00 -2.95%
11 Feb 710.00 -1.68%
10 Feb 734.00 -3.13%
07 Feb 722.00 1.93%
06 Feb 744.00 -2.81%
05 Feb 726.00 2.45%
04 Feb 723.00 -0.34%

Jubilant Ingrevia Limited Graph

Jubilant Ingrevia Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking Target Price for Jubilant Ingrevia Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 601, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 602.45 608.47 547.63 - 669.32
614.50 491.60 - 737.40
620.52 434.37 - 806.68
Bearish Scenario 602.45 596.43 536.78 - 656.07
590.40 472.32 - 708.48
584.38 409.06 - 759.69

Overview of Jubilant Ingrevia Limited

ISIN

INE0BY001018

Industry

Biotechnology

Vol.Avg

602,703

Market Cap

95,688,060,750

Last Dividend

5

Official Website

Visit Website

IPO Date

2021-03-19

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of JUBLINGREA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-02-03 February 03, 25 2.5 2.5 2025-02-03 2025-02-26
2024-08-02 August 02, 24 2.5 2.5 2024-08-02 2024-09-29
2024-02-09 February 09, 24 2.5 2.5 2024-02-09 2024-02-28
2023-08-10 August 10, 23 2.5 2.5 2023-08-10 2023-09-30
2023-02-10 February 10, 23 2.5 2.5 2023-02-10 2023-03-01

Stock Rating Details for JUBLINGREA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 4,100.45 Cr 3,183.85 Cr 916.60 Cr 0.2235 0.00 Cr 387.04 Cr 294.00 Cr 182.89 Cr 11.56 456.42 Cr 0.0446
2023-03-31 4,740.48 Cr 2,581.57 Cr 2,158.91 Cr 0.4554 25.30 Cr 44.84 Cr 444.10 Cr 307.50 Cr 19.34 580.51 Cr 0.0649
2022-03-31 4,914.43 Cr 2,958.48 Cr 1,955.95 Cr 0.3980 0.00 Cr 45.82 Cr 734.09 Cr 476.71 Cr 29.98 863.32 Cr 0.0970
2021-03-31 678.97 Cr 401.39 Cr 277.58 Cr 0.4088 0.00 Cr 6.38 Cr 98.40 Cr 54.36 Cr 20.77 106.78 Cr 0.0801
2020-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.17 Cr -0.17 Cr -0.01 -0.17 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 78.78 Cr 4,731.89 Cr 1,994.42 Cr 2,737.4740 Cr 740.24 Cr 661.46 Cr 964.81 Cr 2,849.63 Cr 11.46 Cr 0.00 Cr 15.49 Cr 1,286.0760 Cr
2023-03-31 72.73 Cr 4,258.88 Cr 1,592.65 Cr 2,666.2300 Cr 406.75 Cr 334.02 Cr 1,035.11 Cr 2,356.90 Cr 109.66 Cr 216.13 Cr 8.24 Cr 1,179.5800 Cr
2022-03-31 37.46 Cr 3,797.15 Cr 1,364.08 Cr 2,433.0680 Cr 237.84 Cr 200.38 Cr 911.16 Cr 1,958.28 Cr 101.42 Cr 67.93 Cr 6.19 Cr 1,052.7780 Cr
2021-03-31 73.34 Cr 3,378.52 Cr 1,455.58 Cr 1,922.9390 Cr 555.67 Cr 482.33 Cr 609.10 Cr 1,857.16 Cr 105.77 Cr 525.28 Cr 50.24 Cr 894.3340 Cr
2020-03-31 0.05 Cr 0.05 Cr 0.17 Cr -0.1157 Cr 0.00 Cr -0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.1657 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 429.9790 Cr -569.5020 Cr 144.1340 Cr -138.3960 Cr 6.0590 Cr 78.7840 Cr -568.3750 Cr 267.6110 Cr 336.2730 Cr -78.6210 Cr 93.0300 Cr
2023-03-31 462.4600 Cr -471.8900 Cr 41.6000 Cr -18.9300 Cr 35.1200 Cr 72.7300 Cr -481.3900 Cr 436.7100 Cr 47.2540 Cr -79.3130 Cr -125.8400 Cr
2022-03-31 452.7380 Cr -71.8560 Cr -417.7520 Cr 222.5890 Cr -35.7340 Cr 37.6080 Cr -230.1490 Cr 708.9410 Cr -318.7480 Cr -45.1550 Cr -304.9470 Cr
2021-03-31 112.2810 Cr -43.6550 Cr -72.3650 Cr 84.7360 Cr 73.2920 Cr 73.3420 Cr -27.5450 Cr 77.3870 Cr -62.1880 Cr 0.0000 Cr -37.4140 Cr
2020-03-31 0.3984 Cr 0.0000 Cr 0.0500 Cr 0.3984 Cr 0.4484 Cr 0.0500 Cr 0.0000 Cr -0.1660 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 1,046.06 Cr 538.63 Cr 507.43 Cr 0.4851 0.00 Cr 69.38 Cr 4.39 147.73 Cr 0.0663
2024-09-30 1,045.24 Cr 786.68 Cr 258.56 Cr 0.2474 84.97 Cr 59.00 Cr 3.73 134.89 Cr 0.0564
2024-06-30 1,024.34 Cr 786.88 Cr 237.46 Cr 0.2318 70.65 Cr 48.74 Cr 3.06 109.53 Cr 0.0476
2024-03-31 1,074.44 Cr 835.17 Cr 239.27 Cr 0.2227 55.52 Cr 29.25 Cr 1.85 100.74 Cr 0.0272
2023-12-31 960.45 Cr 508.60 Cr 451.85 Cr 0.4705 70.14 Cr 38.56 Cr 2.43 104.35 Cr 0.0401

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 54.79 Cr 57.78 Cr 112.57 Cr 591.80 Cr 889.37 Cr 1,778.65 Cr 2,975.13 Cr 4,841.29 Cr 2,025.94 Cr
2024-06-30 -79.59 Cr 159.18 Cr 79.59 Cr 0.00 Cr 0.00 Cr 79.59 Cr 0.00 Cr 0.00 Cr -2,737.47 Cr
2024-03-31 79.59 Cr 36.89 Cr 79.59 Cr 571.97 Cr 941.30 Cr 1,779.90 Cr 2,849.63 Cr 4,731.89 Cr 1,994.42 Cr
2023-12-31 -55.61 Cr 111.22 Cr 55.61 Cr 0.00 Cr 0.00 Cr 55.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 46.96 Cr 40.49 Cr 87.45 Cr 454.24 Cr 1,049.56 Cr 1,778.15 Cr 2,572.47 Cr 4,470.32 Cr 1,770.38 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 48.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 29.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 38.56 Cr 68.48 Cr 0.00 Cr 0.00 Cr 68.48 Cr 124.09 Cr 55.61 Cr 0.00 Cr 68.48 Cr
2023-09-30 57.49 Cr 67.82 Cr 0.00 Cr 0.00 Cr 67.82 Cr 55.61 Cr -12.21 Cr 0.00 Cr 67.82 Cr
2023-06-30 57.59 Cr 64.60 Cr 0.00 Cr 0.00 Cr 64.60 Cr 137.65 Cr 73.05 Cr 0.00 Cr 64.60 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹312.20 ₹374,827,320,000.00 ₹2,116,013.00
Syngene International Limited SYNGENE ₹650.00 ₹260,840,646,950.00 ₹202,178.00
Piramal Pharma Limited PPLPHARMA ₹192.10 ₹254,676,229,220.00 ₹2,764,417.00
Concord Biotech Limited CONCORDBIO ₹1,643.45 ₹171,931,493,890.00 ₹251,710.00
Blue Jet Healthcare Limited BLUEJET ₹789.00 ₹136,864,216,380.00 ₹388,513.00
Jubilant Ingrevia Limited JUBLINGREA ₹600.75 ₹95,688,060,750.00 ₹358,426.00
Supriya Lifescience Limited SUPRIYA ₹614.80 ₹49,480,825,440.00 ₹242,967.00
Dishman Carbogen Amcis Limited DCAL ₹204.72 ₹32,096,615,760.00 ₹205,540.00
Zota Health Care Limited ZOTA ₹812.25 ₹22,261,823,100.00 ₹42,771.00

Key Executives

Company Secretary & Compliance Officer
Ms. Deepanjali Gulati

Gender: female

Year Born:

President & Chief Financial Officer
Mr. Varun Gupta

Gender: male

Year Born:

Chief Sustainability Officer
Mr. K.V.S Satish Kumar

Gender: male

Year Born: 1977

President of Speciality Chemicals
Mr. Ambrish Dixit

Gender: male

Year Born:

Co-Chairman & Whole-Time Director
Mr. Hari Shanker Bhartia B.E., B.Tech

Gender: male

Year Born: 1956

President of Operations, Chief Operating Officer & Whole Time Director
Mr. Vijay Kumar Srivastava

Gender: male

Year Born: 1976

Executive Vice President & Head of Legal
Mr. Sanjay Gupta A.C.M.A., B.Com., L.L.B.

Gender: male

Year Born: 1966

SBU Head of Acetyls
Mr. Himanshu Dhapolav

Gender: male

Year Born:

Senior Vice President & Head of Human Resources
Ms. Vinita Koul

Gender: female

Year Born: 1972

Chief Executive Officer, MD & Director
Mr. Deepak Jain

Gender: male

Year Born: 1981

FAQs about Jubilant Ingrevia Limited

Who is the CEO of the company?

The CEO is Mr. Deepak Jain.

What is the current market price of the stock?

The current price is ₹600.75.

What is the 52-week price range?

The range is ₹422-885.

What is the market capitalization of the company?

The market capitalization is ₹9,568.81 crores.

What is the dividend yield?

The dividend yield is 0.83%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 46.01.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Jubilant Ingrevia Limited (ISIN: INE0BY001018) is a leading Biotechnology in India. With a market capitalization of ₹9,568.81 crores and an average daily volume of 602,703 shares, it operates in the Biotechnology. The company last declared a dividend of ₹5.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack